Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuan-Sheng Zang

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
The American Journal of Hospice & Palliative Care|February 9, 2013
Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndromeYuan-Sheng Zang, Zheng Fang, Bing Li
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 4, 2014
BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysisJiquan Chen, Yuan-Sheng Zang, Qingyu Xiu
Rheumatology (Oxford, England)|November 30, 2011
Gout-associated lung diseaseYuan-Sheng Zang, Zheng Fang, Bing Li
Oncotargets and Therapy|January 22, 2019
Complete response with fluorouracil and irinotecan with a BRAF<sup>V600E</sup> and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case reportZhan Wang, Wei-Ping Dai, Yuan-Sheng Zang
Oncology Letters|March 12, 2019
Molecular mechanism of triple-negative breast cancer-associated BRCA1 and the identification of signaling pathwaysFeng Qi, Wen-Xing Qin, Yuan-Sheng Zang
Lung Cancer (Amsterdam, Netherlands)|February 8, 2018
Primary pulmonary leiomyosarcoma: A population-based studyBao-Dong Qin, Xiao-Dong Jiao, Yuan-Sheng Zang
Medical Hypotheses|June 3, 2018
Tumor mutation burden to tumor burden ratio and prediction of clinical benefit of anti-PD-1/PD-L1 immunotherapyBao-Dong Qin, Xiao-Dong Jiao, Yuan-Sheng Zang
Frontiers in Immunology|July 6, 2026
Neural regulation of tumor progression: implications for hepatocellular carcinomaYalin Chen, Zhanghui Long, Yuan-Sheng Zang, et al.
BMC Cancer|February 22, 2018
Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case reportXiao-Dong Jiao, Chunming Ding, Yuan-Sheng Zang, et al.
Frontiers in Oncology|June 28, 2021
Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast CancerWenxing Qin, Feng Qi, Jia Li, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
The American Journal of Hospice & Palliative Care|February 9, 2013
Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndromeYuan-Sheng Zang, Zheng Fang, Bing Li
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 4, 2014
BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysisJiquan Chen, Yuan-Sheng Zang, Qingyu Xiu
Rheumatology (Oxford, England)|November 30, 2011
Gout-associated lung diseaseYuan-Sheng Zang, Zheng Fang, Bing Li
Oncotargets and Therapy|January 22, 2019
Complete response with fluorouracil and irinotecan with a BRAF<sup>V600E</sup> and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case reportZhan Wang, Wei-Ping Dai, Yuan-Sheng Zang
Oncology Letters|March 12, 2019
Molecular mechanism of triple-negative breast cancer-associated BRCA1 and the identification of signaling pathwaysFeng Qi, Wen-Xing Qin, Yuan-Sheng Zang
Lung Cancer (Amsterdam, Netherlands)|February 8, 2018
Primary pulmonary leiomyosarcoma: A population-based studyBao-Dong Qin, Xiao-Dong Jiao, Yuan-Sheng Zang
Medical Hypotheses|June 3, 2018
Tumor mutation burden to tumor burden ratio and prediction of clinical benefit of anti-PD-1/PD-L1 immunotherapyBao-Dong Qin, Xiao-Dong Jiao, Yuan-Sheng Zang
Frontiers in Immunology|July 6, 2026
Neural regulation of tumor progression: implications for hepatocellular carcinomaYalin Chen, Zhanghui Long, Yuan-Sheng Zang, et al.
BMC Cancer|February 22, 2018
Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case reportXiao-Dong Jiao, Chunming Ding, Yuan-Sheng Zang, et al.
Frontiers in Oncology|June 28, 2021
Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast CancerWenxing Qin, Feng Qi, Jia Li, et al.
Pageof 7